---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-002855"
form_type: "8-K"
ticker: "ADIL"
cik: "0001513525"
company_name: "ADIAL PHARMACEUTICALS, INC."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T03:09:59.625917+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Adial Pharmaceuticals updates business development presentation for upcoming meetings

## Summary
- Company will hold business development meetings over the next several weeks.
- Updated business development presentation furnished as Exhibit 99.1.
- Presentation includes forward-looking statements under safe harbor provisions.
- No specific financial data, milestones, or material changes disclosed in the filing.

## SEC filing metadata
- accession: 0001213900-25-002855
- form_type: 8-K
- ticker: ADIL
- cik: 0001513525
- company_name: ADIAL PHARMACEUTICALS, INC.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1513525/000121390025002855/0001213900-25-002855-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1513525/000121390025002855/ea0227475-8k_adial.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-002855
- JSON: https://secwatch.observer/filing/0001213900-25-002855.json
- Plain text: https://secwatch.observer/filing/0001213900-25-002855.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.